Children's Hospital Medical Center - Cincinnati
Cincinnati, Ohio, 45229-3039, United States
NCT Number: NCT00005890
OBJECTIVES:
I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children with septic shock.
II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in children with adrenal dysfunction and septic shock.
Looking for future studies?
Notify Me1 month–18 year
All sexes
Interventional
Not applicable
Cincinnati, Ohio, 45229-3039, United States
PROTOCOL OUTLINE:
Patients undergo a corticotropin stimulation test within 8 hours of admission to the PICU. Blood samples for plasma cortisol and corticotropin levels are drawn at time 0 followed by corticotropin 1-24 IV. Additional cortisol levels are drawn at 30 and 60 minutes. Corticotropin is measured by immunoradiometric assay and cortisol is measured by radioimmunoassay. Mean arterial blood pressure, heart rate, and respiratory rate are recorded at baseline and at 60 minutes.
Patients receive routine management for septic shock and multiple organ system failure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
Patients admitted to the PICU with septic shock; Hypotension (systolic blood pressure less than 2 standard deviations below age normal) plus 3 or more of the following: temperature greater than 38 or less than 36 degrees Celsius; heart rate greater than 90th percentile for age; respiratory rate greater than 90th percentile for age; WBC greater than 12,000/mm3 or less than 4,000/mm3 or greater than 10% band forms; perfusion abnormalities including lactic acidosis, oliguria, or an acute alteration in mental status
Arterial or central venous catheter in place
--Prior/Concurrent Therapy--
At least one month since prior corticosteroids
--Patient Characteristics--
Renal: No nephrotic syndrome requiring glucocorticoids
Pulmonary: No asthma requiring glucocorticoids
Other: No condition requiring glucocorticoids (e.g., adrenal insufficiency); No uncontrolled diabetes mellitus; No prior adrenal dysfunction (plasma cortisol concentration less than 19 mcg/dL 30 and 60 minutes post corticotropin stimulation); No hypersensitivity to corticotropin
National Center for Research Resources (NCRR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02186522
Immune System Diseases, Infections
Edinburgh, United Kingdom
View Trial DetailsNCT05146336
Acute Liver Failure, Acute Respiratory Distress Syndrome
Klagenfurt, Austria
View Trial DetailsNCT07658014
Cardiovascular Diseases, Infections
Querétaro City, Querétaro, Mexico
View Trial DetailsNCT05900284
Acute Kidney Injury, Female Urogenital Diseases
Pittsburgh, Pennsylvania, United States
View Trial Details